Scripps Research findings show potential for HIV treatment.Scripps Research Findings Show Potential For HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. Treatment: Immunologists at The Scripps Research Institute have uncovered the first evidence that an HIV antibody HIV antibody A self antibody specifically directed against one or more proteins or antigens on the surface of HIV, which may be minimally protective against HIV is most effective when it binds not only to the virus, but also to host immune cells. Their work could have further implications in future attempts to design an HIV vaccine HIV vaccine AIDS As of mid-2005, there is no viable anti-HIV vaccine. See AIDS. , according to the institute. The study was published Sept. 6 in the journal Nature. Grant money from the National Institutes of Health and the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative A public-private partnership dedicated to producing a preventive vaccine against HIV infection, suitable for use in the most affected developing countries. To date, no such vaccine exists but scientific consensus suggests that its development is feasible. , and a fellowship from the Swiss National Foundation, funded the study. Send biotechnology industry related news to Heather Chambers, hchambers@sdbj. com, or call (858) 277-6359, ext. 3125. |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion